D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
+1.75%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$47.8B
AUM Growth
+$4.48B
Cap. Flow
+$3.1B
Cap. Flow %
6.49%
Top 10 Hldgs %
13.38%
Holding
2,845
New
285
Increased
887
Reduced
1,059
Closed
433

Sector Composition

1 Communication Services 13.16%
2 Healthcare 11.66%
3 Consumer Discretionary 11.65%
4 Financials 10.86%
5 Technology 10.61%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CACH
2226
DELISTED
CACHE INC (DE)
CACH
$74K ﹤0.01%
22,400
VVTV
2227
DELISTED
VALUEVISION MEDIA INC
VVTV
$71K ﹤0.01%
14,520
-14,746
-50% -$72.1K
GEVO icon
2228
Gevo
GEVO
$392M
$70K ﹤0.01%
10
-4
-29% -$28K
CRIS icon
2229
Curis
CRIS
$22.4M
$66K ﹤0.01%
235
-101
-30% -$28.4K
LXRX icon
2230
Lexicon Pharmaceuticals
LXRX
$392M
$66K ﹤0.01%
5,472
-39,926
-88% -$482K
HNSN
2231
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$64K ﹤0.01%
2,481
-9,634
-80% -$249K
VTG
2232
DELISTED
VANTAGE DRILLING COMPANY ORD SHS (KY)
VTG
$64K ﹤0.01%
37,272
-11,900
-24% -$20.4K
ACLS icon
2233
Axcelis
ACLS
$2.62B
$62K ﹤0.01%
7,192
-16,538
-70% -$143K
IMMU
2234
DELISTED
Immunomedics Inc
IMMU
$60K ﹤0.01%
+14,300
New +$60K
END
2235
DELISTED
ENDEAVOUR INTERNATIONAL CORP NEW (NV)
END
$59K ﹤0.01%
18,031
-143,028
-89% -$468K
TLRA
2236
DELISTED
Telaria, Inc.
TLRA
$58K ﹤0.01%
14,192
-700
-5% -$2.86K
MRGE
2237
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
$55K ﹤0.01%
22,732
+7,566
+50% +$18.3K
ELNK
2238
DELISTED
EarthLink Holdings Corp.
ELNK
$51K ﹤0.01%
14,158
-197,849
-93% -$713K
PGNX
2239
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$48K ﹤0.01%
11,689
-395,074
-97% -$1.62M
STAB
2240
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$46K ﹤0.01%
3,352
-215
-6% -$2.95K
WTSL
2241
DELISTED
WET SEAL INC CL-A
WTSL
$45K ﹤0.01%
34,341
-53,681
-61% -$70.3K
CTIC
2242
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$42K ﹤0.01%
1,237
-41,509
-97% -$1.41M
VRNG
2243
DELISTED
VRINGO, INC COM STK NEW (DE)
VRNG
$41K ﹤0.01%
1,180
-2,235
-65% -$77.7K
ENZN
2244
DELISTED
ENZON PHARMACEUTICALS INC
ENZN
$40K ﹤0.01%
39,311
ATLC icon
2245
Atlanticus Holdings
ATLC
$1.02B
$37K ﹤0.01%
16,155
RSH
2246
DELISTED
RADIOSHACK CORP
RSH
$34K ﹤0.01%
15,891
-15,075
-49% -$32.3K
CERE
2247
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$33K ﹤0.01%
4,761
+1,590
+50% +$11K
NIHD
2248
DELISTED
NII HOLDINGS INC CL B
NIHD
$31K ﹤0.01%
25,782
-112,214
-81% -$135K
GMO
2249
DELISTED
General Moly, Inc.
GMO
$30K ﹤0.01%
29,900
-96,538
-76% -$96.9K
MBOT icon
2250
Microbot Medical
MBOT
$173M
$29K ﹤0.01%
13
-12
-48% -$26.8K